A Look At Abbott Laboratories ABT Valuation After New Cancerguard Early Cancer Detection Data [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Abbott Laboratories (ABT) is back in focus after presenting new multi-biomarker data for its Cancerguard multi cancer early detection test at the 2026 American Association for Cancer Research meeting, alongside recognition for DETECT-A study outcomes. See our latest analysis for Abbott Laboratories. The latest Cancerguard data drop and recent first quarter earnings come against a weaker backdrop, with a 30 day share price return of 13.07% decline and a 1 year total shareholder return of 27.83% decline suggesting momentum has been fading rather than building. If this kind of cancer detection progress has your attention, it could be a good moment to look more widely across healthcare AI, starting with 33 healthcare AI stocks With shares posting double digit declines over 1 year even as revenue and net income show single digit growth and valuation screens flag a discount, is Abbott mispriced today, or is the market already baking in future gains? Most Popular Narrative: 20% Un
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories: Buying A Healthcare Giant On Sale [Seeking Alpha]Seeking Alpha
- This Boring Dividend King Might Be the Safest Pick to Add to Your Portfolio [Yahoo! Finance]Yahoo! Finance
- ?????????????:2026???2036???? [CNET News]CNET News
- Abbott is the most oversold healthcare stock as Q1 earnings roll on [Seeking Alpha]Seeking Alpha
- Abbott Laboratories (ABT) was downgraded by Daiwa Securities Group Inc. from "outperform" to "neutral". They now have a $92.00 price target on the stock.MarketBeat
ABT
Earnings
- 4/16/26 - Beat
ABT
Sec Filings
- 4/24/26 - Form S-8
- 4/17/26 - Form 8-K
- 4/16/26 - Form 8-K
- ABT's page on the SEC website